Daphnoretin

CAS No. 2034-69-7

Daphnoretin( Daphnoretin, NSC 291852,BRN-1299325 )

Catalog No. M18213 CAS No. 2034-69-7

Daphnoretin has anticancer effects on leukemia, osteosarcoma and uterine cervix cancer cells, might through promoting apoptosis in a mitochondria-mediated way.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 127 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Daphnoretin
  • Note
    Research use only, not for human use.
  • Brief Description
    Daphnoretin has anticancer effects on leukemia, osteosarcoma and uterine cervix cancer cells, might through promoting apoptosis in a mitochondria-mediated way.
  • Description
    Daphnoretin, also know as NSC291852, is an active constituent of Wikstroemia indica C. A. Meys which possesses anti-cancer activity. Inhibitory effect on mitosis. Daphnoretin also reduces proliferation, invasion, and migration of HCT116 colon cancer cells in a concentration-dependent manner.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Daphnoretin, NSC 291852,BRN-1299325
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Caspase-3
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    2034-69-7
  • Formula Weight
    352.29
  • Molecular Formula
    C19H12O7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (70.96 mM)
  • SMILES
    COC1=C(C=C2C(=C1)C=C(C(=O)O2)OC3=CC4=C(C=C3)C=CC(=O)O4)O
  • Chemical Name
    7-hydroxy-6-methoxy-3-((2-oxo-2H-chromen-7-yl)oxy)-2H-chromen-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Olanzapine impurity ...

    Olanzapine impurity L HCl is an impurity generated during the production of Olanzapine.

  • GCN2-IN-6

    GCN2-IN-6 is a potent and orally available GCN2 inhibitor confirmed by in-house enzymatic (IC50: 1.8 nM) and cellular assays (IC50: 9.3 nM).?

  • Nimacimab

    Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.